Company profile
Recurv Pharma company profile
Recurv Pharma's RP-001 is a novel chemical entity (NCE) that is administered in a nano-emulsion formulation, concentrating medication delivery to the tumour while preserving healthy organs. Strong efficacy in a variety of pre-clinical tumour models, including non-small cell lung, breast, ovarian, prostate, pancreatic, and colorectal cancers, has allowed the chemical to show that it can destroy tumours even in multi-drug resistant tumours.
Business identity
- Operating status
- Active
- Company type
- For Profit
- Founded
- 2022-01-01, Year
Headquarters
- Headquarters
- Karavelove, Mykolaiv, Ukraine
- Postal code
- 19808
- Country code
- UA
- Continent
- Europe